US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

0.8378

+0.191729.67%

Post-market: 0.84990.0121+1.44%19:59 EDT

Volume:5.47M

Turnover:4.27M

Market Cap:100.50M

PE:-0.58

High:0.8600

Open:0.7060

Low:0.6700

Close:0.6461

Loading ...

Overview Company News Filings

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody

Simply Wall St.

Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial

Simply Wall St.

The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live

Top Midday Decliners

MT Newswires Live

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live

Invivyd Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright

Invivyd's FDA Setback Highlight's Risks of Pipeline Concentration -- Market Talk

5 Stocks That More Than Doubled Halfway Through Q1

Invivyd Shares Fall 25% After FDA Declines to Expand Emergency Use Authorization of Co's Covid-19 Drug

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live

Invivyd Is Maintained at Buy by D. Boral Capital

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA

MT Newswires Live

BUZZ-Invivyd falls after US FDA declines to expand emergency use of COVID-19 drug

Invivyd Shares Down 31.1% Premarket After FDA Declines to Expand Emergency Use Authorization of Co's Covid-19 Drug

THOMSON REUTERS

FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of Pemgarda™ (Pemivibart) to Include Treatment of Mild-to-Moderate Covid-19 for Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing Pemgarda Eua for Pre-Exposure Prophylaxis of Covid-19 in Certain Immunocompromised Patients

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IVVD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVVD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":0.8378,"timestamp":1747080000000,"preClose":0.6461,"halted":0,"volume":5472213,"hourTrading":{"tag":"盘后","latestPrice":0.8499,"preClose":0.8378,"latestTime":"19:59 EDT","volume":121765,"amount":102020.1254,"timestamp":1747094390918},"delay":0,"floatShares":47996766,"shares":119961445,"eps":-1.4333,"marketStatus":"Closed","change":0.1917,"latestTime":"05-12 16:00:00 EDT","open":0.706,"high":0.86,"low":0.67,"amount":4267813.55780829,"amplitude":0.294072,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.4333,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747123200000},"marketStatusCode":5,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":0.6461,"preHourTrading":{"tag":"盘前","latestPrice":0.6898,"preClose":0.6461,"latestTime":"09:22 EDT","volume":70531,"amount":49950.230527499996,"timestamp":1747056130850},"postHourTrading":{"tag":"盘后","latestPrice":0.8499,"preClose":0.8378,"latestTime":"19:59 EDT","volume":121765,"amount":102020.1254,"timestamp":1747094390918},"volumeRatio":1.487953,"impliedVol":3.1407,"impliedVolPercentile":0.952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","floatShares":47996766,"roa":"-61.64%","roe":"-138.71%","lyrEps":-1.4333,"volumeRatio":1.487953,"shares":119961445,"dividePrice":0,"high":0.86,"amplitude":0.294072,"preClose":0.6461,"low":0.67,"week52Low":0.3546,"pbRate":"1.49","psRate":"3.96","week52High":2.74,"institutionHeld":0,"latestPrice":0.8378,"eps":-1.4333,"divideRate":0,"volume":5472213,"delay":0,"ttmEps":-1.4333,"open":0.706,"prevYearClose":0.4431,"prevWeekClose":0.6461,"prevMonthClose":0.6302,"prevQuarterClose":0.6053,"fiveDayClose":0.5754,"twentyDayClose":0.549,"sixtyDayClose":1.38,"earningDate":1747238400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVVD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517600480","title":"Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600480","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600480?lang=en_us&edition=fundamental","pubTime":"2025-03-05 02:16","pubTimestamp":1741112188,"startTime":"0","endTime":"0","summary":"Invivyd has seen its share price surge by an impressive 163% over the past month, driven primarily by the positive data released from its Phase 1/2 clinical trial of VYD2311, a novel monoclonal antibody candidate against COVID-19. The clinical trial results highlighted improved efficacy and a favorable safety profile, sparking investor enthusiasm amid market conditions characterized by significant volatility due to newly imposed U.S. tariffs. While major indices like the Dow Jones and S&P 500 declined by around 1.8% as investors assessed economic impacts of these tariffs, Invivyd's strong trial data likely contributed to investor confidence in its innovative approach to COVID-19 treatments. The broader market, despite its recent 2.5% decline, remains 13% higher year-on-year, adding a positive backdrop for companies like Invivyd making forward strides in healthcare advancements. This performance underscores the importance of strategic progress in challenging environments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/invivyd-nasdaqgm-ivvd-jumps-163-181628369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","IVVD","BK4139"],"gpt_icon":0},{"id":"2514363253","title":"Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514363253","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514363253?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:04","pubTimestamp":1740683057,"startTime":"0","endTime":"0","summary":"Invivyd (NasdaqGM:IVVD) experienced a significant 198% price increase over the past month, likely driven by the release of positive clinical data for its novel monoclonal antibody candidate, VYD2311. The promising results from the Phase 1/2 trial revealed improved safety and enhanced antiviral potency, positioning the company as a potential leader in COVID-19 treatment alternatives. This advancement coincides with a mixed performance in the broader U.S. stock market, where major indices...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/invivyd-nasdaqgmivvd-surges-198-after-positive-results-from","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BNTX","BK4548","BK4535","BK4551","BK4588","IVVD","BK4568","BK4585"],"gpt_icon":1},{"id":"2514605310","title":"The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514605310","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514605310?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:21","pubTimestamp":1740478860,"startTime":"0","endTime":"0","summary":"Chicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: INVIVYD INC. IVVD, 21Vianet Group, Inc. VNET, FuboTV FUBO, Noodles & Co. NDLS and Digital Turbine Inc. APPS.5 Stocks that More than Doubled Halfway Through Q1. As such, we have highlighted five stocks from different sectors that more than doubled halfway through the first quarter and have a Zacks Rank #1  or #2 . These are INVIVYD INC., 21Vianet Group, Inc., FuboTV, Noodles & Co. and Digital Turbine Inc. You can see the complete list of today’s Zacks #1 Rank stocks here.President Donald Trump's tariff talks, which could lead to a global trade war, have been weighing on the stock market. Trump’s 25% tariff on goods from Mexico and Canada, which was delayed by a month, is set to take effect next month. Early this month,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-invivyd-102100034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4077","BK4588","BK4531","VNET","APPS","BK4507","BK4535","IVVD","BK4209","BK4585","NDLS","FUBO","BK4607","BK4116","BK4023","BK4139","LU1046422090.SGD","BK4524"],"gpt_icon":1},{"id":"2514705385","title":"Sector Update: Health Care Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514705385?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:51","pubTimestamp":1740430269,"startTime":"0","endTime":"0","summary":"Health care stocks gained late Monday afternoon with the NYSE Health Care Index climbing 1.1% and the Health Care Select Sector SPDR Fund  rising 0.9%.The iShares Biotechnology ETF  was up 0.1%.In corporate news, Amneal Pharmaceuticals  shares jumped 7% after JPMorgan upgraded the stock to overweight from neutral and raised its price target to $12 from $9.PepGen  shares surged 66% after it reported initial positive data from a phase 1 trial investigating PGN-EDODM1 in myotonic dystrophy type 1.Amgen  will invest an initial $200 million this year in its new technology center in southern India, Reuters reported, citing Chief Executive Robert Bradway. Amgen confirmed the plans in a statement sent to MT Newswires, saying that the investment would back the acceleration of its digital capabilities through AI and data science. Amgen shares rose 2%.Invivyd  dropped 31% after the firm said the US Food and Drug Administration rejected its request to expand the existing emergency use authorizatio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1061106388.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","AMGN","LU2242652126.USD","SG9999001440.SGD","LU1057294990.SGD","BK4139","LU1571399168.USD","BK4534","IE00BJT1NW94.SGD","LU2112291526.USD","LU0058720904.USD","AMRX","IE0009355771.USD","LU2242646821.SGD","LU0109394709.USD","BK4599","LU0289739699.SGD","BK4007","BK4566","LU0889565916.HKD","IVVD","BK4588","BK4585","LU0122379950.USD","IBB","IE0002141913.USD","BK4581","BK4533","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU1023059063.AUD","XLV","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1983299246.USD","PEPG"],"gpt_icon":0},{"id":"2514377734","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2514377734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514377734?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:55","pubTimestamp":1740423334,"startTime":"0","endTime":"0","summary":"Target Hospitality  shares slumped 44% amid heavy trading after the company said Monday it received a notice from the US government that it plans to discontinue the current Pecos Children's Center services agreement with Target's nonprofit partner.Intraday trading volume soared to over 9.3 million shares from a daily average of about 489,000.Invivyd  said Monday that the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised adults and adolescents.Shares slid 23% as intraday trading volume stood at over 11.7 million compared with the stock's daily average of about 14.8 million.Summit Therapeutics  shares dropped 13% after the company reported a Q4 non-GAAP net loss of $0.07 per diluted share, widening from a loss of $0.04 a year earlier.More than 4.74 million shares traded intraday versus its daily average of roughly 2.23 million.Price: 5.25, Change: -4.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TH","LU2488822045.USD","SMMT","IVVD","BK4142","BK4139"],"gpt_icon":0},{"id":"2514777806","title":"Sector Update: Health Care Stocks Gain Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777806","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514777806?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:52","pubTimestamp":1740423127,"startTime":"0","endTime":"0","summary":"Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund  climbing 1%.The iShares Biotechnology ETF  advanced 0.4%.In corporate news, Amgen  will invest an initial $200 million this year in its new technology center in southern India, Reuters reported, citing Chief Executive Robert Bradway. Amgen confirmed the plans in a statement sent to MT Newswires, saying that the investment would back the acceleration of its digital capabilities through AI and data science. Amgen shares rose 2.3%.Invivyd  sank 24% after the firm said the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised persons.Summit Therapeutics  shares fell 13% following its Q4 results.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SMMT","BK4533","SG9999001440.SGD","LU0320765992.SGD","LU0289739699.SGD","BK4581","BK4599","LU1057294990.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2488822045.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0109394709.USD","XLV","IE00B4R5TH58.HKD","LU1983299246.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0868494617.USD","BK4588","BK4566","LU0889565916.HKD","LU1571399168.USD","LU0122379950.USD","BK4534","IBB","IVVD","IE0002141913.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2514577579","title":"Invivyd Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514577579","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514577579?lang=en_us&edition=fundamental","pubTime":"2025-02-25 00:25","pubTimestamp":1740414300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVVD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 11:25 ET (16:25 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD"],"gpt_icon":0},{"id":"2513733767","title":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733767","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513733767?lang=en_us&edition=fundamental","pubTime":"2025-02-24 23:46","pubTimestamp":1740412013,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF15L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMRN","IVVD","TWLO","LU1981816686.USD","SMMT","LU2750360997.AUD","WING","YYAI","DPZ","MACW.SI","AAPL","PDD","LU1778281490.HKD","LU0345770993.USD","HOOD","AXSM","TUYA","BCRX","CTAS","LU0198837287.USD","LU1769817179.HKD","SMCI","ZH","BRDG","CRL","LU2756315318.SGD","GFI","SUI","GOOS","OC","AMRX","PODD","AZUL","BBWI","LU0594300419.USD","U","CEG","FDP","IE00B775H168.HKD","LU0823434740.USD","TRDA","XYZ","LU0823397103.USD","ARMK","NKE","HE","AU","PLTR","ABR","AGIO"],"gpt_icon":0},{"id":"2513720183","title":"Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513720183?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:56","pubTimestamp":1740408963,"startTime":"0","endTime":"0","summary":"H.C. Wainwright maintains a Buy rating on Invivyd (IVVD) with a $10 price target after the FDA rejected its submission to expand Pemgarda’s Emergen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-news-disappointing-but-not-in-model-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-news-disappointing-but-not-in-model-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2513271837","title":"Invivyd's FDA Setback Highlight's Risks of Pipeline Concentration -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2513271837","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513271837?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:48","pubTimestamp":1740408480,"startTime":"0","endTime":"0","summary":"0947 ET - While D. Boral Capital says Invivyd's guidance didn't include the potential expansion of its Pemgarda drug use, analyst Jason Kolbert says it shows the challenges in securing approvals for COVID-19 therapeutics and reinforces the importance of pipeline diversification to sustain long-term growth. Pemgarda is a monoclonal antibody medication authorized for the pre-exposure prophylaxis of COVID19. Kolbert says Invivyd remains engaged with the FDA in pursuit of a regulatory pathway for its medication while preparing to provide additional data and regulatory correspondence to underscore its position. Invivyd tumbles 27% to $1.30. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2514775111","title":"5 Stocks That More Than Doubled Halfway Through Q1","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775111","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514775111?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:37","pubTimestamp":1740407820,"startTime":"0","endTime":"0","summary":"After a weak start to 2025, Wall Street regained momentum, driven by solid corporate earnings and advancements in AI. The S&P 500 touched record highs on several occasions, having risen 2.2%, while the Dow Jones and the Nasdaq Composite Index have gained 2.1% and 1.1%, respectively, since the start of the year. The gains came despite concerns over slowdown and trade war fears.As such, we have highlighted five stocks from different sectors that more than doubled halfway through the first quarter and have a Zacks Rank #1  or #2 . These are INVIVYD INC. IVVD, 21Vianet Group, Inc. VNET, FuboTV FUBO, Noodles & Company NDLS and Digital Turbine Inc. APPS. You can see the complete list of today’s Zacks #1 Rank stocks here.INVIVYD is a biopharmaceutical company that is involved in developing antibodies to transcend the li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-stocks-more-doubled-halfway-143700157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IVVD","APPS","BK4531","BK4585","LU1046422090.SGD","VNET","NDLS","BK4209","BK4139","BK4077","FUBO","BK4116","BK4607","BK4535","BK4023","BK4588","BK4507","BK4524"],"gpt_icon":1},{"id":"2513072269","title":"Invivyd Shares Fall 25% After FDA Declines to Expand Emergency Use Authorization of Co's Covid-19 Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2513072269","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513072269?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:32","pubTimestamp":1740407567,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2513722885","title":"BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722885","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722885?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:25","pubTimestamp":1740407154,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Twilio, Bath & Body Works, WingstopEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL6N3PF0C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD","OC","ARMK","NVD","WING","NVD3.UK","TWLO","NVDS.UK","TRDA","LU0788109477.HKD","LU0211331839.USD","NVDD","DPZ","NVDU","AXSM","NVDS","NVD2.UK","BRDG","NVDX","SNVD.UK","CTAS","AMRX","AU","NVIW.SI","SMMT","LU2097344357.USD","BBWI","2NVD.UK","FDP","3NVD.UK","AGIO","IVVD","ABR","NVDY","IE00B2PGVK34.USD","LU1718418525.SGD","LU1303367103.USD","LU1923622614.USD","SG9999001176.USD","MACW.SI","LU1162221912.USD","LU2552382058.USD"],"gpt_icon":1},{"id":"2513724103","title":"Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724103","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724103?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:14","pubTimestamp":1740406493,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher pre-bell Monday, with the iShares Biotechnology ETF  inactive and The Health Care Select Sector SPDR Fund  up 0.3%.Invivyd  shares were down past 28% after the company said the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised adults and adolescents.Summit Therapeutics  stock was over 5% higher after the company said it will collaborate with Pfizer  on a set of clinical trials to evaluate ivonescimab, its investigational drug, in combination with several Pfizer antibody drug conjugates to treat multiple solid tumors.Entrada Therapeutics  shares were up more than 5% after the company said the US Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and cleared the company's plan to start a phase 1b study of the product candidate as a potential treatment for adults with Duchenne muscular dystrop","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985481810.HKD","LU0234572021.USD","IE00BBT3K403.USD","BK4581","TRDA","SG9999001176.SGD","LU1023059063.AUD","LU0058720904.USD","LU0225771236.USD","LU1894683264.USD","SG9999002224.SGD","LU1883839398.USD","SG9999002232.USD","SG9999011175.SGD","LU0289739699.SGD","BK4534","PFE.AU","LU0306807586.USD","BK4550","IVVD","IBB","LU0306806265.USD","BK4139","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999013999.USD","LU0122379950.USD","XLV","LU0170899867.USD","IE00BLSP4452.SGD","SMMT","LU1057294990.SGD","IE000M9KFDE8.USD","LU2488822045.USD","BK4599","LU0321505868.SGD","BK7095","LU0868494617.USD","SGXZ57979304.SGD","LU1066053197.SGD","SG9999003800.SGD","BK4568","BK4592","LU0456855351.SGD","IE0002270589.USD","LU0225284248.USD","BK4007","BK4588"],"gpt_icon":1},{"id":"2513817726","title":"Invivyd Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2513817726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513817726?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:58","pubTimestamp":1740401880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVVD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 07:58 ET (12:58 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD"],"gpt_icon":0},{"id":"2513268187","title":"Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2513268187","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513268187?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:48","pubTimestamp":1740401280,"startTime":"0","endTime":"0","summary":"Invivyd's stock fell sharply in pre-market trading Monday after U.S. regulators denied a request for its drug Pemgarda to be used in treating Covid-19 in more cases.Shares traded 37% lower ahead of the morning bell at $1.12.The  commercial-stage biopharmaceutical company said its request to expand the existing emergency use authorization of the drug, also called pemivibart, to treat mild-to-moderate Covid-19 in more people was declined by the Food and Drug Administration.Invivyd wanted to expand its use to adults and adolescents who have moderate-to-severe immune compromise due to certain medical conditions such as cancer and organ transplant, where other alternative Covid-19 treatment options weren't possible.The recent denial by the FDA doesn't affect its existing emergency use authorization for pre-exposure prophylaxis of Covid-19 in certain immunocompromised patients, which still remains in effect, Invivyd said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4535","BK4551","IVVD","BK4568","BK4585","BK4588","BNTX","BK4139"],"gpt_icon":0},{"id":"2513725553","title":"Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2513725553","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513725553?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:46","pubTimestamp":1740401199,"startTime":"0","endTime":"0","summary":"Invivyd  said Monday that the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate Covid-19 in immunocompromised adults and adolescents.The drug, also called pemivibart, is already being used as a preventative measure for some immunocompromised patients who are not currently sick with Covid-19, the company said.Invivyd said its application for pemivibart as a Covid-19 treatment option was not considered in its current financial guidance and that it plans to publicly share detailed data and regulatory correspondence regarding pemivibart in comparison with other drugs.Shares of the company were down more than 34% in recent premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4585","BK4535","BK4139","BK4548","BK4588","BK4551","BNTX","IVVD"],"gpt_icon":0},{"id":"2513723004","title":"BUZZ-Invivyd falls after US FDA declines to expand emergency use of COVID-19 drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723004","media":"Reuters","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723004?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:41","pubTimestamp":1740400891,"startTime":"0","endTime":"0","summary":"BUZZ-Invivyd falls after US FDA declines to expand emergency use of COVID-19 drug** Shares of drugmaker Invivyd IVVD.O fall 37.2% to $1.11 premarket** Co says the U.S. FDA has declined to expand the emergency use authorization of its COVID-19 prevention drug ** The expansion was to include those whose immunity is impaired by certain conditions such as cancer and organ transplant, and for whom alternative options are not accessible or appropriate** The drug Pemgarda is already authorized for emergency use in those with compromised immunity due to a medical condition or receiving medicines that suppress the immune system, and unlikely to have an adequate response to vaccination ** IVVD fell 88.8% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF0RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2513072847","title":"Invivyd Shares Down 31.1% Premarket After FDA Declines to Expand Emergency Use Authorization of Co's Covid-19 Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2513072847","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513072847?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:14","pubTimestamp":1740399262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF0ZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2513164740","title":"FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of Pemgarda™ (Pemivibart) to Include Treatment of Mild-to-Moderate Covid-19 for Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing Pemgarda Eua for Pre-Exposure Prophylaxis of Covid-19 in Certain Immunocompromised Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2513164740","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513164740?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:05","pubTimestamp":1740398716,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF17D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVVD\",params:#limit:5,,,undefined,":[{"date":"2025-05-15","symbol":"IVVD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.04,"defaultRemindTime":1747296000000,"name":null,"time":"Pre-Market","dateTimestamp":1747281600000,"actualEps":null},{"market":"US","date":"2025-03-20","symbol":"IVVD","fiscalQuarterEnding":"2024/12","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-02-03","symbol":"IVVD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738558800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"IVVD","fiscalQuarterEnding":"2024/09","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.51},{"date":"2024-10-29","symbol":"IVVD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730188800000,"name":null,"time":"Pre-Market","dateTimestamp":1730174400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVVD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVVD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1730520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVVD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVVD","date":"2025-05-09","current":-0.416521,"percent":0.921824,"low":-54.35026,"twenty":-2.69425,"median":-1.060024,"eighty":-0.594913,"high":-0.170743,"avg":-4.057862,"sd":9.086083,"marketCap":70777252},"quantilePoints":[{"date":"2021-08-06","current":-20.235974,"twenty":-12.209882,"median":-0.170743,"eighty":-0.170743,"marketCap":2265932260},{"date":"2021-08-13","current":-25.837695,"twenty":-26.477338,"median":-22.901153,"eighty":-8.196835,"marketCap":2893187455},{"date":"2021-08-20","current":-26.787468,"twenty":-26.857247,"median":-25.973377,"eighty":-21.081078,"marketCap":2999538682},{"date":"2021-08-27","current":-29.442955,"twenty":-27.834156,"median":-26.254432,"eighty":-22.790669,"marketCap":3296888030},{"date":"2021-09-03","current":-41.082517,"twenty":-30.582682,"median":-26.903767,"eighty":-24.407221,"marketCap":4600233167},{"date":"2021-09-10","current":-52.237501,"twenty":-34.346884,"median":-27.107289,"eighty":-25.864831,"marketCap":5849317474},{"date":"2021-09-17","current":-49.87276,"twenty":-41.574848,"median":-28.333272,"eighty":-25.990822,"marketCap":5584524623},{"date":"2021-09-24","current":-43.437403,"twenty":-45.837563,"median":-31.3425,"eighty":-26.070293,"marketCap":4863922575},{"date":"2021-10-01","current":-27.799143,"twenty":-45.332177,"median":-32.752622,"eighty":-26.167208,"marketCap":3112821446},{"date":"2021-10-08","current":-34.098162,"twenty":-44.772716,"median":-31.663999,"eighty":-26.477338,"marketCap":3818156971},{"date":"2021-10-15","current":-32.220379,"twenty":-44.391197,"median":-31.942189,"eighty":-26.810728,"marketCap":3607891333},{"date":"2021-10-22","current":-33.531847,"twenty":-43.143316,"median":-32.796234,"eighty":-26.944471,"marketCap":3754743525},{"date":"2021-10-29","current":-29.050998,"twenty":-41.908316,"median":-32.394248,"eighty":-27.107289,"marketCap":3252998538},{"date":"2021-11-05","current":-19.910465,"twenty":-41.574848,"median":-31.842835,"eighty":-27.107289,"marketCap":2229483266},{"date":"2021-11-12","current":-19.016283,"twenty":-41.160049,"median":-31.463508,"eighty":-26.167208,"marketCap":2129356772},{"date":"2021-11-19","current":-10.754495,"twenty":-40.958465,"median":-30.898976,"eighty":-23.930397,"marketCap":2232820816},{"date":"2021-11-26","current":-13.460534,"twenty":-40.462257,"median":-30.670462,"eighty":-19.910465,"marketCap":2794641699},{"date":"2021-12-03","current":-24.557973,"twenty":-40.277958,"median":-30.278016,"eighty":-20.235974,"marketCap":5098663577},{"date":"2021-12-10","current":-17.806272,"twenty":-39.274486,"median":-29.442955,"eighty":-19.910465,"marketCap":3696892661},{"date":"2021-12-17","current":-6.15155,"twenty":-36.830387,"median":-28.396375,"eighty":-19.016283,"marketCap":1277169056},{"date":"2021-12-23","current":-4.640455,"twenty":-35.773265,"median":-28.318734,"eighty":-17.731253,"marketCap":963439375},{"date":"2021-12-31","current":-3.890266,"twenty":-34.889434,"median":-27.107289,"eighty":-10.888458,"marketCap":807687051},{"date":"2022-01-07","current":-3.177586,"twenty":-34.726181,"median":-26.845617,"eighty":-10.250797,"marketCap":659722343},{"date":"2022-01-14","current":-3.054341,"twenty":-34.716142,"median":-26.109059,"eighty":-6.024018,"marketCap":634134462},{"date":"2022-01-21","current":-3.370492,"twenty":-34.344559,"median":-25.973377,"eighty":-4.803353,"marketCap":699772941},{"date":"2022-01-28","current":-3.633058,"twenty":-33.758373,"median":-25.150086,"eighty":-4.146402,"marketCap":754286254},{"date":"2022-02-04","current":-4.41004,"twenty":-33.472235,"median":-24.833935,"eighty":-4.117466,"marketCap":915601161},{"date":"2022-02-11","current":-3.750945,"twenty":-33.414609,"median":-22.901153,"eighty":-4.037089,"marketCap":778761620},{"date":"2022-02-18","current":-3.440152,"twenty":-33.038815,"median":-20.249744,"eighty":-3.881692,"marketCap":714235657},{"date":"2022-02-25","current":-3.499096,"twenty":-32.761344,"median":-19.910465,"eighty":-3.803458,"marketCap":726473339},{"date":"2022-03-04","current":-2.695322,"twenty":-32.644704,"median":-19.383891,"eighty":-3.620198,"marketCap":559595849},{"date":"2022-03-11","current":-2.706039,"twenty":-32.425048,"median":-19.016283,"eighty":-3.495881,"marketCap":561820883},{"date":"2022-03-18","current":-2.663171,"twenty":-32.232302,"median":-18.082234,"eighty":-3.447654,"marketCap":552920750},{"date":"2022-03-25","current":-2.121963,"twenty":-32.069361,"median":-13.460534,"eighty":-3.399428,"marketCap":440556573},{"date":"2022-04-01","current":-2.185863,"twenty":-31.771301,"median":-10.864345,"eighty":-3.292258,"marketCap":495731781},{"date":"2022-04-08","current":-1.866688,"twenty":-31.632206,"median":-10.454419,"eighty":-3.196877,"marketCap":423346167},{"date":"2022-04-14","current":-1.736117,"twenty":-31.536113,"median":-10.036457,"eighty":-2.990039,"marketCap":393733871},{"date":"2022-04-22","current":-1.426614,"twenty":-31.313407,"median":-6.874947,"eighty":-2.80142,"marketCap":323541760},{"date":"2022-04-29","current":-1.38309,"twenty":-31.137425,"median":-5.513889,"eighty":-2.691035,"marketCap":313670994},{"date":"2022-05-06","current":-1.392762,"twenty":-30.873144,"median":-5.106644,"eighty":-2.665314,"marketCap":315864498},{"date":"2022-05-13","current":-1.033486,"twenty":-30.749945,"median":-4.774417,"eighty":-2.440927,"marketCap":298425270},{"date":"2022-05-20","current":-1.120876,"twenty":-30.64463,"median":-4.321625,"eighty":-2.212136,"marketCap":323659760},{"date":"2022-05-27","current":-1.132275,"twenty":-30.523419,"median":-4.206417,"eighty":-2.074048,"marketCap":326951215},{"date":"2022-06-03","current":-1.200668,"twenty":-30.451885,"median":-4.15819,"eighty":-1.963408,"marketCap":346699946},{"date":"2022-06-10","current":-1.124676,"twenty":-30.104147,"median":-3.970643,"eighty":-1.784476,"marketCap":324756912},{"date":"2022-06-17","current":-1.033486,"twenty":-30.05447,"median":-3.890266,"eighty":-1.562021,"marketCap":298425270},{"date":"2022-06-24","current":-1.27695,"twenty":-29.565258,"median":-3.847398,"eighty":-1.481744,"marketCap":368726981},{"date":"2022-07-01","current":-1.330156,"twenty":-29.129389,"median":-3.775058,"eighty":-1.43822,"marketCap":384090605},{"date":"2022-07-08","current":-1.569584,"twenty":-28.687364,"median":-3.66253,"eighty":-1.432587,"marketCap":453226914},{"date":"2022-07-15","current":-1.527779,"twenty":-28.386662,"median":-3.584832,"eighty":-1.439301,"marketCap":441155495},{"date":"2022-07-22","current":-1.580986,"twenty":-28.330364,"median":-3.496417,"eighty":-1.441122,"marketCap":456519119},{"date":"2022-07-29","current":-1.337757,"twenty":-28.318734,"median":-3.466945,"eighty":-1.439301,"marketCap":386285408},{"date":"2022-08-05","current":-1.520179,"twenty":-28.006979,"median":-3.442832,"eighty":-1.418008,"marketCap":438960692},{"date":"2022-08-12","current":-1.516378,"twenty":-27.384031,"median":-3.402643,"eighty":-1.425167,"marketCap":437863290},{"date":"2022-08-19","current":-1.549068,"twenty":-27.107289,"median":-3.34102,"eighty":-1.426035,"marketCap":457088205},{"date":"2022-08-26","current":-1.69291,"twenty":-26.985176,"median":-3.279398,"eighty":-1.431485,"marketCap":499532109},{"date":"2022-09-02","current":-1.762987,"twenty":-26.833988,"median":-3.247247,"eighty":-1.435834,"marketCap":520209909},{"date":"2022-09-09","current":-1.696599,"twenty":-26.632403,"median":-3.150793,"eighty":-1.43839,"marketCap":500620415},{"date":"2022-09-16","current":-1.416291,"twenty":-26.283507,"median":-2.973964,"eighty":-1.43839,"marketCap":417909216},{"date":"2022-09-23","current":-1.095413,"twenty":-26.089676,"median":-2.842681,"eighty":-1.425167,"marketCap":323226659},{"date":"2022-09-30","current":-1.166035,"twenty":-26.025711,"median":-2.786416,"eighty":-1.403926,"marketCap":344065403},{"date":"2022-10-07","current":-1.188387,"twenty":-25.919104,"median":-2.692642,"eighty":-1.367291,"marketCap":350660906},{"date":"2022-10-14","current":-1.221915,"twenty":-25.585157,"median":-2.679246,"eighty":-1.335295,"marketCap":360554160},{"date":"2022-10-21","current":-1.370929,"twenty":-25.161339,"median":-2.598869,"eighty":-1.327097,"marketCap":404524180},{"date":"2022-10-28","current":-1.464063,"twenty":-25.020946,"median":-2.452181,"eighty":-1.331555,"marketCap":432005442},{"date":"2022-11-04","current":-1.318774,"twenty":-24.880554,"median":-2.304152,"eighty":-1.330032,"marketCap":389134673},{"date":"2022-11-11","current":-1.402279,"twenty":-24.72355,"median":-2.205207,"eighty":-1.330032,"marketCap":392336643},{"date":"2022-11-18","current":-1.071185,"twenty":-24.116213,"median":-2.120061,"eighty":-1.321288,"marketCap":299701602},{"date":"2022-11-25","current":-0.833577,"twenty":-23.232604,"median":-2.052303,"eighty":-1.304144,"marketCap":233222338},{"date":"2022-12-02","current":-0.903691,"twenty":-22.029676,"median":-1.963408,"eighty":-1.287526,"marketCap":252839170},{"date":"2022-12-09","current":-0.771253,"twenty":-20.652703,"median":-1.869106,"eighty":-1.273678,"marketCap":215785153},{"date":"2022-12-16","current":-0.631026,"twenty":-20.24699,"median":-1.781428,"eighty":-1.254406,"marketCap":176551489},{"date":"2022-12-23","current":-0.662187,"twenty":-20.170872,"median":-1.761143,"eighty":-1.246835,"marketCap":185270081},{"date":"2022-12-30","current":-0.584283,"twenty":-19.910465,"median":-1.729267,"eighty":-1.233091,"marketCap":163473601},{"date":"2023-01-06","current":-0.646606,"twenty":-19.910465,"median":-1.709507,"eighty":-1.220425,"marketCap":180910785},{"date":"2023-01-13","current":-0.864739,"twenty":-19.727655,"median":-1.700287,"eighty":-1.204982,"marketCap":241940930},{"date":"2023-01-20","current":-0.705035,"twenty":-19.324279,"median":-1.696599,"eighty":-1.18418,"marketCap":197258145},{"date":"2023-01-27","current":-0.966014,"twenty":-19.073908,"median":-1.680001,"eighty":-1.168577,"marketCap":270276354},{"date":"2023-02-03","current":-0.817996,"twenty":-19.036154,"median":-1.663404,"eighty":-1.145789,"marketCap":228863042},{"date":"2023-02-10","current":-0.697244,"twenty":-18.849703,"median":-1.652339,"eighty":-1.126955,"marketCap":195078497},{"date":"2023-02-17","current":-0.759568,"twenty":-18.510377,"median":-1.599988,"eighty":-1.120876,"marketCap":212515681},{"date":"2023-02-24","current":-0.669978,"twenty":-18.137426,"median":-1.580986,"eighty":-1.092453,"marketCap":187449729},{"date":"2023-03-03","current":-0.681663,"twenty":-17.656234,"median":-1.570639,"eighty":-1.028927,"marketCap":190719201},{"date":"2023-03-10","current":-0.689454,"twenty":-15.84292,"median":-1.562021,"eighty":-1.00081,"marketCap":192898849},{"date":"2023-03-17","current":-0.588178,"twenty":-12.481002,"median":-1.538592,"eighty":-0.965462,"marketCap":164563425},{"date":"2023-03-24","current":-0.592742,"twenty":-10.968835,"median":-1.527779,"eighty":-0.894342,"marketCap":143038670},{"date":"2023-03-31","current":-0.54297,"twenty":-10.872382,"median":-1.517437,"eighty":-0.884215,"marketCap":131027790},{"date":"2023-04-06","current":-0.538445,"twenty":-10.810224,"median":-1.510673,"eighty":-0.88032,"marketCap":129935891},{"date":"2023-04-14","current":-0.534538,"twenty":-10.69448,"median":-1.497376,"eighty":-0.857727,"marketCap":128993146},{"date":"2023-04-21","current":-0.539068,"twenty":-10.424412,"median":-1.489775,"eighty":-0.829682,"marketCap":130086308},{"date":"2023-04-28","current":-0.511888,"twenty":-10.250797,"median":-1.484646,"eighty":-0.81488,"marketCap":123527335},{"date":"2023-05-05","current":-0.534538,"twenty":-10.004306,"median":-1.471564,"eighty":-0.788392,"marketCap":128993146},{"date":"2023-05-12","current":-0.888336,"twenty":-9.42023,"median":-1.465302,"eighty":-0.768137,"marketCap":156322203},{"date":"2023-05-19","current":-0.777692,"twenty":-7.308984,"median":-1.45367,"eighty":-0.771253,"marketCap":136852082},{"date":"2023-05-26","current":-0.914566,"twenty":-6.075459,"median":-1.441122,"eighty":-0.771297,"marketCap":160938049},{"date":"2023-06-02","current":-0.933231,"twenty":-5.771097,"median":-1.436569,"eighty":-0.771471,"marketCap":164222499},{"date":"2023-06-09","current":-0.839908,"twenty":-5.513889,"median":-1.428574,"eighty":-0.777692,"marketCap":147800249},{"date":"2023-06-16","current":-0.796357,"twenty":-5.358493,"median":-1.425167,"eighty":-0.783914,"marketCap":140136532},{"date":"2023-06-23","current":-0.659483,"twenty":-5.277043,"median":-1.40727,"eighty":-0.771253,"marketCap":116050565},{"date":"2023-06-30","current":-0.703034,"twenty":-5.076636,"median":-1.402434,"eighty":-0.766514,"marketCap":123714282},{"date":"2023-07-07","current":-0.696812,"twenty":-4.903021,"median":-1.400732,"eighty":-0.759568,"marketCap":122619465},{"date":"2023-07-14","current":-0.858572,"twenty":-4.803353,"median":-1.392762,"eighty":-0.759568,"marketCap":151084699},{"date":"2023-07-21","current":-0.902123,"twenty":-4.720832,"median":-1.38309,"eighty":-0.76184,"marketCap":158748415},{"date":"2023-07-28","current":-0.902123,"twenty":-4.548289,"median":-1.369067,"eighty":-0.766093,"marketCap":158748415},{"date":"2023-08-04","current":-0.920788,"twenty":-4.339308,"median":-1.356759,"eighty":-0.767358,"marketCap":162032865},{"date":"2023-08-11","current":-0.964339,"twenty":-4.226779,"median":-1.354805,"eighty":-0.768916,"marketCap":169696582},{"date":"2023-08-18","current":-1.071184,"twenty":-4.212847,"median":-1.341126,"eighty":-0.771253,"marketCap":187682117},{"date":"2023-08-25","current":-1.115033,"twenty":-4.206417,"median":-1.331904,"eighty":-0.77134,"marketCap":195365010},{"date":"2023-09-01","current":-1.165147,"twenty":-4.187126,"median":-1.325058,"eighty":-0.771471,"marketCap":204145460},{"date":"2023-09-08","current":-1.108769,"twenty":-4.137828,"median":-1.318774,"eighty":-0.772715,"marketCap":194267454},{"date":"2023-09-15","current":-1.102505,"twenty":-4.046734,"median":-1.300575,"eighty":-0.778936,"marketCap":193169898},{"date":"2023-09-22","current":-1.039863,"twenty":-3.993149,"median":-1.292152,"eighty":-0.783914,"marketCap":182194335},{"date":"2023-09-29","current":-1.108769,"twenty":-3.92456,"median":-1.28265,"eighty":-0.784498,"marketCap":194267454},{"date":"2023-10-06","current":-1.02107,"twenty":-3.890266,"median":-1.27286,"eighty":-0.788392,"marketCap":178901667},{"date":"2023-10-13","current":-1.033598,"twenty":-3.885979,"median":-1.257306,"eighty":-0.794625,"marketCap":181096779},{"date":"2023-10-20","current":-0.989749,"twenty":-3.864545,"median":-1.253862,"eighty":-0.794971,"marketCap":173413885},{"date":"2023-10-27","current":-1.039863,"twenty":-3.855972,"median":-1.250062,"eighty":-0.795664,"marketCap":182194335},{"date":"2023-11-03","current":-0.970956,"twenty":-3.824892,"median":-1.24107,"eighty":-0.80009,"marketCap":170121217},{"date":"2023-11-10","current":-0.876993,"twenty":-3.803458,"median":-1.233091,"eighty":-0.803649,"marketCap":153657873},{"date":"2023-11-17","current":-0.974107,"twenty":-3.770235,"median":-1.223778,"eighty":-0.807025,"marketCap":165172440},{"date":"2023-11-24","current":-0.967613,"twenty":-3.727368,"median":-1.213951,"eighty":-0.8088,"marketCap":164071290},{"date":"2023-12-01","current":-0.993589,"twenty":-3.668424,"median":-1.20606,"eighty":-0.8088,"marketCap":168475888},{"date":"2023-12-08","current":-1.097493,"twenty":-3.624484,"median":-1.192112,"eighty":-0.81092,"marketCap":186094282},{"date":"2023-12-15","current":-1.116976,"twenty":-3.600907,"median":-1.17787,"eighty":-0.815659,"marketCap":189397731},{"date":"2023-12-22","current":-2.435267,"twenty":-3.563398,"median":-1.186164,"eighty":-0.817996,"marketCap":412931100},{"date":"2023-12-29","current":-2.545665,"twenty":-3.531247,"median":-1.195838,"eighty":-0.817996,"marketCap":431650643},{"date":"2024-01-05","current":-2.435267,"twenty":-3.511956,"median":-1.203364,"eighty":-0.820333,"marketCap":412931100},{"date":"2024-01-12","current":-2.688534,"twenty":-3.495881,"median":-1.213437,"eighty":-0.826566,"marketCap":455875934},{"date":"2024-01-19","current":-2.883356,"twenty":-3.48945,"median":-1.221915,"eighty":-0.829682,"marketCap":488910422},{"date":"2024-01-26","current":-2.876862,"twenty":-3.47659,"median":-1.233091,"eighty":-0.83124,"marketCap":487809272},{"date":"2024-02-02","current":-3.117141,"twenty":-3.460515,"median":-1.235593,"eighty":-0.833621,"marketCap":528551808},{"date":"2024-02-09","current":-3.272998,"twenty":-3.448726,"median":-1.249027,"eighty":-0.836175,"marketCap":554979398},{"date":"2024-02-16","current":-2.88069,"twenty":-3.448726,"median":-1.254147,"eighty":-0.839908,"marketCap":488458412},{"date":"2024-02-23","current":-2.831627,"twenty":-3.444439,"median":-1.259169,"eighty":-0.842397,"marketCap":480139169},{"date":"2024-03-01","current":-2.754528,"twenty":-3.436937,"median":-1.274905,"eighty":-0.852491,"marketCap":467066072},{"date":"2024-03-08","current":-2.670421,"twenty":-3.41979,"median":-1.284551,"eighty":-0.853832,"marketCap":452804513},{"date":"2024-03-15","current":-2.558277,"twenty":-3.401571,"median":-1.29463,"eighty":-0.857273,"marketCap":433789100},{"date":"2024-03-22","current":-2.165774,"twenty":-3.391926,"median":-1.301003,"eighty":-0.858572,"marketCap":367235156},{"date":"2024-03-28","current":-2.393164,"twenty":-3.370492,"median":-1.318774,"eighty":-0.858572,"marketCap":475385316},{"date":"2024-04-05","current":-2.148639,"twenty":-3.311549,"median":-1.327504,"eighty":-0.860844,"marketCap":426812003},{"date":"2024-04-12","current":-1.833545,"twenty":-3.311549,"median":-1.333653,"eighty":-0.864739,"marketCap":364220857},{"date":"2024-04-19","current":-1.410419,"twenty":-3.279398,"median":-1.341342,"eighty":-0.864794,"marketCap":280169890},{"date":"2024-04-26","current":-1.242369,"twenty":-3.274039,"median":-1.341126,"eighty":-0.864794,"marketCap":246787946},{"date":"2024-05-03","current":-1.422423,"twenty":-3.272998,"median":-1.339441,"eighty":-0.864794,"marketCap":282554315},{"date":"2024-05-10","current":-1.452432,"twenty":-3.268681,"median":-1.354074,"eighty":-0.871015,"marketCap":288515376},{"date":"2024-05-17","current":-1.412314,"twenty":-3.26001,"median":-1.355782,"eighty":-0.876993,"marketCap":292092013},{"date":"2024-05-24","current":-1.158674,"twenty":-3.225813,"median":-1.354074,"eighty":-0.877237,"marketCap":239634672},{"date":"2024-05-31","current":-1.043383,"twenty":-3.211609,"median":-1.341126,"eighty":-0.879703,"marketCap":215790426},{"date":"2024-06-07","current":-1.009596,"twenty":-3.192472,"median":-1.333025,"eighty":-0.88032,"marketCap":208802627},{"date":"2024-06-14","current":-0.98075,"twenty":-3.181982,"median":-1.330053,"eighty":-0.88032,"marketCap":202836837},{"date":"2024-06-21","current":-0.755755,"twenty":-3.174189,"median":-1.321916,"eighty":-0.87847,"marketCap":156303680},{"date":"2024-06-28","current":-0.692294,"twenty":-3.170792,"median":-1.318774,"eighty":-0.877188,"marketCap":143178944},{"date":"2024-07-05","current":-0.634603,"twenty":-3.142038,"median":-1.315549,"eighty":-0.864794,"marketCap":131247365},{"date":"2024-07-12","current":-0.674987,"twenty":-3.119885,"median":-1.301003,"eighty":-0.859935,"marketCap":139599470},{"date":"2024-07-15","current":-0.686525,"twenty":-3.118513,"median":-1.300575,"eighty":-0.858572,"marketCap":141985786},{"date":"2024-08-02","current":-0.68941,"twenty":-3.117141,"median":-1.300147,"eighty":-0.858572,"marketCap":142582365},{"date":"2024-08-09","current":-0.605758,"twenty":-3.097659,"median":-1.294588,"eighty":-0.848061,"marketCap":125281576},{"date":"2024-08-16","current":-0.60941,"twenty":-3.065189,"median":-1.28637,"eighty":-0.833577,"marketCap":124220340},{"date":"2024-08-23","current":-0.514541,"twenty":-3.055914,"median":-1.279565,"eighty":-0.817996,"marketCap":104882577},{"date":"2024-08-30","current":-0.517764,"twenty":-3.054341,"median":-1.273965,"eighty":-0.8088,"marketCap":105539512},{"date":"2024-09-06","current":-0.498896,"twenty":-3.052629,"median":-1.268761,"eighty":-0.804006,"marketCap":101693459},{"date":"2024-09-13","current":-0.673867,"twenty":-3.052201,"median":-1.254795,"eighty":-0.793067,"marketCap":137359030},{"date":"2024-09-20","current":-0.714885,"twenty":-3.043957,"median":-1.250062,"eighty":-0.776448,"marketCap":145720014},{"date":"2024-09-27","current":-0.60941,"twenty":-3.030682,"median":-1.247269,"eighty":-0.770474,"marketCap":124220340},{"date":"2024-10-04","current":-0.562884,"twenty":-3.005449,"median":-1.242369,"eighty":-0.759568,"marketCap":114736595},{"date":"2024-10-11","current":-0.529894,"twenty":-2.97914,"median":-1.234118,"eighty":-0.750739,"marketCap":108011974},{"date":"2024-10-18","current":-0.61527,"twenty":-2.95253,"median":-1.22564,"eighty":-0.739313,"marketCap":125414766},{"date":"2024-10-25","current":-0.57935,"twenty":-2.944451,"median":-1.213951,"eighty":-0.734142,"marketCap":118092933},{"date":"2024-10-31","current":-0.533292,"twenty":-2.934797,"median":-1.206537,"eighty":-0.729185,"marketCap":108704742},{"date":"2024-11-08","current":-0.585971,"twenty":-2.925172,"median":-1.195838,"eighty":-0.709709,"marketCap":119442635},{"date":"2024-11-15","current":-0.419997,"twenty":-2.922744,"median":-1.180905,"eighty":-0.703113,"marketCap":94556475},{"date":"2024-11-22","current":-0.371808,"twenty":-2.92249,"median":-1.17407,"eighty":-0.697071,"marketCap":83707301},{"date":"2024-11-29","current":-0.37117,"twenty":-2.91193,"median":-1.166035,"eighty":-0.69059,"marketCap":83563762},{"date":"2024-12-06","current":-0.303269,"twenty":-2.891149,"median":-1.165147,"eighty":-0.68557,"marketCap":68276832},{"date":"2024-12-13","current":-0.308104,"twenty":-2.88229,"median":-1.162672,"eighty":-0.679326,"marketCap":69365338},{"date":"2024-12-20","current":-0.228302,"twenty":-2.879159,"median":-1.158778,"eighty":-0.673873,"marketCap":51399010},{"date":"2024-12-27","current":-0.281805,"twenty":-2.876862,"median":-1.150014,"eighty":-0.673867,"marketCap":63444344},{"date":"2025-01-03","current":-0.255027,"twenty":-2.876862,"median":-1.146355,"eighty":-0.669978,"marketCap":57415696},{"date":"2025-01-10","current":-0.245198,"twenty":-2.874317,"median":-1.138593,"eighty":-0.663197,"marketCap":55202800},{"date":"2025-01-17","current":-0.233403,"twenty":-2.868171,"median":-1.132275,"eighty":-0.656796,"marketCap":52547324},{"date":"2025-01-24","current":-0.222245,"twenty":-2.85831,"median":-1.128781,"eighty":-0.646866,"marketCap":50035387},{"date":"2025-01-31","current":-0.207209,"twenty":-2.840038,"median":-1.124676,"eighty":-0.643039,"marketCap":46650253},{"date":"2025-02-07","current":-1.051985,"twenty":-2.823791,"median":-1.121298,"eighty":-0.64111,"marketCap":236839749},{"date":"2025-02-14","current":-0.733202,"twenty":-2.818476,"median":-1.120876,"eighty":-0.643039,"marketCap":165070128},{"date":"2025-02-21","current":-0.64288,"twenty":-2.812485,"median":-1.118477,"eighty":-0.643031,"marketCap":144735402},{"date":"2025-02-28","current":-0.658819,"twenty":-2.803591,"median":-1.116976,"eighty":-0.644411,"marketCap":148323883},{"date":"2025-03-07","current":-0.547245,"twenty":-2.801008,"median":-1.110663,"eighty":-0.636245,"marketCap":123204516},{"date":"2025-03-14","current":-0.431473,"twenty":-2.796913,"median":-1.108769,"eighty":-0.631096,"marketCap":97140182},{"date":"2025-03-21","current":-0.521427,"twenty":-2.792516,"median":-1.102505,"eighty":-0.62713,"marketCap":88603523},{"date":"2025-03-28","current":-0.43064,"twenty":-2.784875,"median":-1.097493,"eighty":-0.619015,"marketCap":73176481},{"date":"2025-04-04","current":-0.388282,"twenty":-2.77135,"median":-1.096241,"eighty":-0.613037,"marketCap":65978794},{"date":"2025-04-11","current":-0.356513,"twenty":-2.754107,"median":-1.09048,"eighty":-0.611536,"marketCap":60580529},{"date":"2025-04-17","current":-0.332722,"twenty":-2.752176,"median":-1.083864,"eighty":-0.609696,"marketCap":56537829},{"date":"2025-04-25","current":-0.471868,"twenty":-2.738793,"median":-1.080862,"eighty":-0.606488,"marketCap":80182229},{"date":"2025-05-02","current":-0.428663,"twenty":-2.703896,"median":-1.071184,"eighty":-0.598126,"marketCap":72840589},{"date":"2025-05-09","current":-0.416521,"twenty":-2.69425,"median":-1.060024,"eighty":-0.594913,"marketCap":70777252}],"updateTime":1747097368569}}}